STEVEN MATES: Open Payments
NPI 1477923423 · KETTERING, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$46,435 in 194 payments from 10 companies in 2025. Trend: 2023 $27,294 · 2024 $32,203 · 2025 $46,435
Speaker / faculty: $21,056Honoraria: $17,500Food & beverage: $4,254Travel & lodging: $2,229Consulting: $1,395
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 45 | $20,244 |
| ABBVIE INC. | 57 | $9,797 |
| Otsuka America Pharmaceutical, Inc. | 19 | $7,968 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $6,456 |
| E.R. Squibb & Sons, L.L.C. | 17 | $561 |
| Janssen Pharmaceuticals, Inc | 7 | $460 |
| Lundbeck LLC | 14 | $410 |
| Vanda Pharmaceuticals Inc. | 11 | $289 |
| Neurocrine BioSciences, Inc. | 12 | $221 |
| Alkermes, Inc. | 1 | $29 |
Products named: Auvelity, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, COBENFY, SPRAVATO, REXULTI, INGREZZA.
Industry payments across OH — which companies pay providers there.
